Page 105 - 80_02

Almudena
Gómez-­-Hernández
&
al.

40. Boucher
J,
Castan-­-Laurell
I,
Le
Lay
S,
Grujic
D,
Sibrac
D,
Krief
S
et
al.
Human
alpha
2A-­-
adrenergic
receptor
gene
expressed
in
transgenic
mouse
adipose
tissue
under
the
control

of
its
regulatory
elements.
J
Mol
Endocrinol.
2002;
29(2):251-­-64.

41. Frühbeck
G,
Gómez-­-Ambrosi
J,
Muruzábal
FJ,
Burrell
MA.
The
adipocyte:
a
model
for

integration
of
endocrine
and
metabolic
signaling
in
energy
metabolism
regulation.
Am
J

Physiol
Endocrinol
Metab.
2001;
280(6):E827-­-47.

42. Martí
A,
Berraondo
B,
Martínez
JA.
Leptin:
physiological
actions.
J
Physiol
Biochem.
1999;

55(1):43-­-9.

43. Mueller
WM,
Gregoire
FM,
Stanhope
KL,
Mobbs
CV,
Mizuno
TM,
Warden
CH
et
al.
Evidence

that
glucose
metabolism
regulates
leptin
secretion
from
cultured
rat
adipocytes.

Endocrinology.
1998;
139(2):551-­-8.

44. Wellhoener
P,
Fruehwald-­-Schultes
B,
Kern
W,
Dantz
D,
Kerner
W,
Born
J
et
al.
Glucose

metabolism
rather
than
insulin
is
a
main
determinant
of
leptin
secretion
in
humans.
J
Clin

Endocrinol
Metab.
2000;
85(3):1267-­-71.

45. Nakata
M,
Yada
T,
Soejima
N,
Maruyama
I.
Leptin
promotes
aggregation
of
human
platelets

via
the
long
form
of
its
receptor.
Diabetes.
1999;
48(2):426-­-429.

46. Mcgill,
JB,
Schneider,
DJ,
Arfken,
CL,
Lucore,
CL.
Factors
responsable
for
impaired

fibrinolysis
in
obese
subject
and
NIDDM
patiens.
Diabetes
1994;
43(1):
104-­-109.

47. Palomer
X,
Pérez
A,
Blanco-­-Vaca
F.
Adiponectin:
a
new
link
between
obesity,
insulin

resistance
and
cardiovascular
disease.
Med
Clin
(Barc)
2005;
124(10):388-­-95.

48. Arita
Y,
Kihara
S,
Ouchi
N,
Takahashi
M,
Maeda
K,
Miyagawa
J
et
al.
Paradoxical
decrease
of

an
adipose-­-specific
protein,
adiponectin,
in
obesity.
Biochem
Biophys
Res
Commun.
1999;

257(1):79-­-83.

49. Hotta
K,
Funahashi
T,
Arita
Y,
Takahashi
M,
Matsuda
M,
Okamoto
Y
et
al.
Plasma

concentrations
of
a
novel,
adipose-­-specific
protein,
adiponectin,
in
type
2
diabetic
patients.

Arterioscler
Thromb
Vasc
Biol.
2000;
20(6):1595-­-9.

50. Pischon
T,
Girman
CJ,
Hotamisligil
GS,
Rifai
N,
Hu
FB,
Rimm
EB.
Plasma
adiponectin
levels

and
risk
of
myocardial
infarction
in
men.
JAMA.
2004;
291(14):1730-­-7.

51. Kazumi
T,
Kawaguchi
A,
Sakai
K,
Hirano
T,
Yoshino
G.
Young
men
with
high-­-normal
blood

pressure
have
lower
serum
adiponectin,
smaller
LDL
size,
and
higher
elevated
heart
rate

than
those
with
optimal
blood
pressure.
Diabetes
Care.
2002;
25(6):971-­-6.

52. Kubota
N,
Terauchi
Y,
Yamauchi
T,
Kubota
T,
Moroi
M,
Matsui
J
et
al.
Disruption
of

adiponectin
causes
insulin
resistance
and
neointimal
formation.
J
Biol
Chem.
2002;

277(29):25863-­-6.

53. Ouchi
N,
Kihara
S,
Arita
Y,
Nishida
M,
Matsuyama
A,
Okamoto
Y
et
al.
Adipocyte-­-derived

plasma
protein,
adiponectin,
suppresses
lipid
accumulation
and
class
A
scavenger

receptor
expression
in
human
monocyte-­-derived
macrophages.
Circulation.
2001;

103(8):1057-­-63.

54. Ryo
M,
Nakamura
T,
Kihara
S,
Kumada
M,
Shibazaki
S,
Takahashi
M
et
al.
Adiponectin
as
a

biomarker
of
the
metabolic
syndrome.
Circ
J.
2004;
68(11):975-­-81.

55. Kumada
M,
Kihara
S,
Sumitsuji
S,
Kawamoto
T,
Matsumoto
S,
Ouchi
N
et
al.
Osaka
CAD

Study
Group.
Coronary
artery
disease.
Association
of
hypoadiponectinemia
with
coronary

artery
disease
in
men.
Arterioscler
Thromb
Vasc
Biol.
2003;
23(1):85-­-9.

56. Steppan
CM,
Bailey
ST,
Bhat
S,
Brown
EJ,
Banerjee
RR,
Wright
CM,
Patel
HR,
Ahima
RS,

Lazar
MA.
The
hormone
resistin
links
obesity
to
diabetes.
Nature.
2001
Jan

18;409(6818):307-­-12.

57. Patel
L,
Buckels
AC,
Kinghorn
IJ,
Murdock
PR,
Holbrook
JD,
Plumpton
C
et
al.

Resistin
is

expressed
in
human
macrophages
and
directly
regulated
by
PPAR
gamma
activators.

Biochem
Biophys
Res
Commun
2003;
300(2):472-­-6.

58. Hotamisligil
GS,
Arner
P,
Caro
JF,
Atkinson
RL,
Spiegelman
BM.
Increased
adipose
tissue

expression
of
tumor
necrosis
factor-­-alpha
in
human
obesity
and
insulin
resistance.
J
Clin

Invest
1995;
95(5):2409–2415.

59. Hotamisligil
GS.
Inflammation
and
metabolic
disorders.
Nature.
2006;
444(7121):860–867

60. Duncan
ER,
Walker
SJ,
Ezzat
VA,
Wheatcroft
SB,
Li
JM,
Shah
AM,
et
al.
Accelerated

endothelial
dysfunction
in
mild
prediabetic
insulin
resistance:
the
early
role
of
reactive

oxygen
species.
Am
J
Physiol
Endocrinol
Metab.
2007;
293(5):E1311–E1319.

61. Hotamisligil
GS,
Budavari
A,
Murray
D,
Spiegelman
BM.
Reduced
tyrosine
kinase
activity
of

the
insulin
receptor
in
obesitydiabetes.
Central
role
of
tumor
necrosis
factor.
J
Clin
Invest

1994;
94(4):1543–1549

342